CIK 0001321732
- Large accelerated filer
Penumbra Inc
Sign in to watch- Ticker
- PEN
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-995-2486
- Business address
- ONE PENUMBRA PLACE, ALAMEDA, CA, 94502
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CFO and Head of Strategy sold 5,000 shares at an average $159.96 ($799,802)
- 4 Open-market sale Director sold 175 shares at an average $160.67 ($28,117)
- 4 Open-market sale Chairman, CEO and President sold 8,000 shares at an average $165.08 ($1,320,650)
- 4 Open-market sale CFO and Head of Strategy sold 5,000 shares at an average $142.89 ($714,461)
- 4 Open-market sale Chairman, CEO and President sold 8,000 shares at an average $125.30 ($1,002,399)
- 4 Open-market sale CFO and Head of Strategy sold 5,000 shares at an average $130.25 ($651,226)
- 4 Shares withheld for taxes CFO and Head of Strategy gave up 79,615 shares (to pay taxes)
- 4 Open-market sale Chairman, CEO and President sold 8,000 shares at an average $141.58 ($1,132,617)
- 4 Exercise or conversion EVP and Chief Business Officer acquired 4,500 shares (option exercise)
- 4 Open-market sale CFO and Head of Strategy sold 5,000 shares at an average $143.45 ($717,251)
- 4 Open-market sale Director sold 304 shares at $148.43 ($45,123)
- 4 Open-market sale Director sold 175 shares at an average $145.72 ($25,501)
- 4 Open-market sale Chief Innovator sold 55,000 shares at $160.07 ($8,803,850)
- 4 Open-market sale Chairman, CEO and President sold 8,000 shares at an average $139.86 ($1,118,843)
- 4 Open-market sale CFO and Head of Strategy sold 5,000 shares at an average $139.84 ($699,220)
- 4 Grant or award Director acquired 949 shares (grant or award)
- 4 Grant or award Director acquired 949 shares (grant or award)
- 4 Grant or award Director acquired 949 shares (grant or award)
- 4 Grant or award Director acquired 949 shares (grant or award)
Page 20 of 30 · 595 filings